Valuence Merger I approved a one-month extension of its initial business combination deadline to August 3, 2026.Key Highlights:Original SEC Filing: Valuence Merger Corp. I [ VMCAF ] - 8-K - Jul. 06, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important informa…
SEALSQ Sees 1H Rev $11M >LAES
Vertex Pharmaceuticals NASDAQ:VRTX will buy Crinetics Pharmaceuticals NASDAQ:CRNX for a total equity value of about $10 billion, the companies said on Monday, adding treatments for rare hormonal diseases to its portfolio.Vertex's offer of $85 per Crinetics share represents a 102% premium to the sto…
Control Empresarial De Capitales S.A. De C.V., a 10% owner, reported the direct sale of Class A Common Shares on 2026-07-01. The shares were sold at a weighted average price of $46.9433 per share with individual prices ranging from $46.50 to $47.41. The total sale amount reported was $9,388,660. Fo…
Vancouver, British Columbia--(Newsfile Corp. - July 6, 2026) - Goldgroup Mining Inc. TSXV:GGA (OTCQX: GGAZF) (FSE: 55G0) ("Goldgroup" or the "Company") is pleased to announce that the British Columbia Supreme Court has granted the final order in connection with the Company's plan of arrangement and…
Hometown Financial Group, Inc. Announces Agreement To Acquire Primary Bank And Plan For Mutual-to-Stock Conversion PRMY
Longeveron Names Marie Washburn as Financial Chief
Longeveron: Washburn to Succeed Lisa Locklear on July 13 >LGVN
Geneva, Switzerland, July 06, 2026 (GLOBE NEWSWIRE) --Preliminary H1 2026 revenue of approximately $11 million, increased 120% vs. H1 2025, underscoring strong operating momentum.Supported by approximately $495 million in cash and short-term investments, and an active pipeline exceeding $225 millio…
MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. CSE:VREO OTCQX:VREOF (“Vireo” or the “Company”), today announced that it has engaged the services of Independent Trading Group ("ITG") to provide market-making services in accordance with Canadian Securities Exchange (“CSE”) policies…
Kalaris Therapeutics Names Laurie Keating to Board
Kalaris Therapeutics: Keating to Succeed Morana Jovan-Embiricos on Aug. 1
Vertex Pharmaceuticals NASDAQ:VRTX will buy Crinetics Pharmaceuticals NASDAQ:CRNX for a total equity value of about $10 billion, the companies said on Monday.
Vertex Pharmaceuticals Sees Crinetics Deal Helping Non-GAAP Operating Income in 2029 >VRTX
PHILADELPHIA, July 06, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) NASDAQ:CNTX, a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, today announced that the Company was added to the small-cap Russel…
Vertex Sees Crinetics's Palsonify, Atumelnant Potentially Adding More Than $5B in Combined Annual Revenue
Vertex Pharmaceuticals Sees Crinetics Deal Immediately Helping Revenue Growth
ABIVAX/ Key word(s): Capital IncreaseAbivax Announces Closing of $920 Million Public Offering06.07.2026 / 22:05 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax Announces Closing of $920 Million Public OfferingPARIS, France, July 6, 2026 –10:05 p.m. CEST – Abivax…
Abivax Announces Closing of $920 Million Public OfferingPARIS, France, July 6, 2026 –10:05 p.m. CEST – Abivax SA (Euronext Paris:FR0012333284 – ABVX / NASDAQ:ABVX (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural r…
Breakthrough Therapy Designation granted for pevifoscorvir sodium in ChinaSOUTH SAN FRANCISCO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. NASDAQ:ALGS, a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver…
